HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide, published by Te Aho o Te Kahu, Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7NZ/cca/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Colorectal Adjuvant FOLFOX (a7) - XML Representation

Active as of 2020-06-29

Raw xml | Download

<PlanDefinition xmlns="http://hl7.org/fhir">
  <id value="ColoRectal"/>
  <meta>
    <profile
             value="http://hl7.org.nz/fhir/StructureDefinition/CcaPlanDefinition"/>
  </meta>
  <text>
    <status value="additional"/>
    <div xmlns="http://www.w3.org/1999/xhtml">Plan for ColoRectal cancer. There is a single cycle with 2 drug administrations</div>
  </text>
  <contained>
    <ActivityDefinition>
      <id value="ActTragacanth"/>
      <meta>
        <profile
                 value="http://hl7.org.nz/fhir/StructureDefinition/CcaActivityDefinition"/>
      </meta>
      <text>
        <status value="additional"/>
        <div xmlns="http://www.w3.org/1999/xhtml">Tragacanth administration, 3mg over 3 hours by continuous IV infusion</div>
      </text>
      <status value="draft"/>
      <productCodeableConcept>
        <coding>
          <system value="https://nzulm.org.nz/nzmt"/>
          <code value="10711851000116105"/>
          <display value="Tragacanth"/>
        </coding>
      </productCodeableConcept>
      <dosage>
        <text value="3 mg over 3 hours by IV infusion"/>
        <route>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="180177004"/>
            <display value="continuous intravenous infusion"/>
          </coding>
        </route>
        <doseAndRate>
          <doseQuantity>
            <value value="3"/>
            <system value="http://unitsofmeasure.org"/>
            <code value="mg"/>
          </doseQuantity>
          <rateQuantity>
            <value value="3"/>
            <system value="http://unitsofmeasure.org"/>
            <code value="h"/>
          </rateQuantity>
        </doseAndRate>
      </dosage>
    </ActivityDefinition>
  </contained>
  <extension
             url="http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions">
    <valueMarkdown value="Only for women"/>
  </extension>
  <extension
             url="http://hl7.org.nz/fhir/StructureDefinition/sact-disclaimer">
    <valueMarkdown value="Developed with the best of intentions."/>
  </extension>
  <extension
             url="http://hl7.org.nz/fhir/StructureDefinition/sact-regimen-type">
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="dummy"/>
      </coding>
      <text value="Folfox"/>
    </valueCodeableConcept>
  </extension>
  <extension
             url="http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor">
    <extension url="factor">
      <valueCodeableConcept>
        <coding>
          <system value="http://snomed.info/sct"/>
          <code value="TOUPDATE-SUPPORT4"/>
          <display value="Diarrhoea risk"/>
        </coding>
      </valueCodeableConcept>
    </extension>
    <extension url="value">
      <valueCodeableConcept>
        <text value="low"/>
      </valueCodeableConcept>
    </extension>
  </extension>
  <extension
             url="http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor">
    <extension url="factor">
      <valueCodeableConcept>
        <coding>
          <system value="http://snomed.info/sct"/>
          <code value="TOUPDATE-SUPPORT8"/>
          <display value="AntiFungal Prophylaxis"/>
        </coding>
      </valueCodeableConcept>
    </extension>
    <extension url="value">
      <valueCodeableConcept>
        <text value="low"/>
      </valueCodeableConcept>
    </extension>
  </extension>
  <extension
             url="http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor">
    <extension url="factor">
      <valueCodeableConcept>
        <coding>
          <system value="http://snomed.info/sct"/>
          <code value="TOUPDATE-SUPPORT2"/>
          <display value="Hypersensitivity / Infusion related reaction ris"/>
        </coding>
      </valueCodeableConcept>
    </extension>
    <extension url="value">
      <valueCodeableConcept>
        <text value="low"/>
      </valueCodeableConcept>
    </extension>
  </extension>
  <url value="http://hl7.org.nz/fhir/ig/cca/PlanDefinition/ColoRectal"/>
  <version value="0.1.0"/>
  <title value="Colorectal Adjuvant FOLFOX (a7)"/>
  <type>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
      <code value="clinical-protocol"/>
    </coding>
  </type>
  <status value="active">
    <extension
               url="http://hl7.org.nz/fhir/StructureDefinition/sact-additional-plan-status">
      <valueCode value="review"/>
    </extension>
  </status>
  <experimental value="false"/>
  <date value="2020-06-29T20:14:18.417+12:00"/>
  <publisher value="Te Aho o Te Kahu, Cancer Control Agency"/>
  <description
               value="A drug treatment regimen for Colorectal cancer. Plan is still under review."/>
  <useContext>
    <code>
      <system
              value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
      <code value="focus"/>
    </code>
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="781382000"/>
        <display value="Colorectal cancer"/>
      </coding>
    </valueCodeableConcept>
  </useContext>
  <relatedArtifact>
    <type value="citation"/>
    <display value="test"/>
    <url value="http://www.ncbi.nlm.nih.gov/pubmed/23434"/>
    <document>
      <url value="http://www.ncbi.nlm.nih.gov/pubmed/23434"/>
    </document>
  </relatedArtifact>
  <relatedArtifact>
    <type value="citation"/>
    <display value="test2"/>
    <url value="http://www.ncbi.nlm.nih.gov/pubmed/34324"/>
    <document>
      <url value="http://www.ncbi.nlm.nih.gov/pubmed/34324"/>
    </document>
  </relatedArtifact>
  <action>
    <extension
               url="http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions">
      <valueMarkdown value="Ensure not pregnant before starting"/>
    </extension>
    <title value="This is the only cycle in the regimen."/>
    <description
                 value="Administration of Cabergoline and Tragacanth. Cycle length 14 days"/>
    <timingTiming>
      <repeat>
        <count value="1"/>
        <duration value="14"/>
        <durationUnit value="d"/>
      </repeat>
    </timingTiming>
    <selectionBehavior value="all"/>
    <action>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions">
        <valueMarkdown value="Keep a close eye for side effects"/>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
        <extension url="day">
          <valueInteger value="1"/>
        </extension>
        <extension url="instructions">
          <valueString
                       value="Specific instructions for the day 1 administration"/>
        </extension>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
        <extension url="day">
          <valueInteger value="4"/>
        </extension>
        <extension url="instructions">
          <valueString
                       value="Specific instructions for the day 4 administration"/>
        </extension>
      </extension>
      <description
                   value="2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes"/>
      <definitionCanonical value="#act-cabergoline"/>
    </action>
    <action>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
        <extension url="day">
          <valueInteger value="2"/>
        </extension>
        <extension url="instructions">
          <valueString
                       value="Specific instructions for the day 2 administration"/>
        </extension>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
        <extension url="day">
          <valueInteger value="3"/>
        </extension>
        <extension url="instructions">
          <valueString
                       value="Specific instructions for the day 3 administration"/>
        </extension>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days">
        <extension url="day">
          <valueInteger value="4"/>
        </extension>
        <extension url="instructions">
          <valueString
                       value="Specific instructions for the day 4 administration"/>
        </extension>
      </extension>
      <description
                   value="3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours"/>
      <definitionCanonical value="#act-tragacanth"/>
    </action>
  </action>
</PlanDefinition>